Product Introduction:
Glimixia VM 0.2/500/2 Mg Tablet ER is a prescription medication used to treat type 2 diabetes mellitus in adults. It combines three antidiabetic agents—Glimepiride, Metformin, and Voglibose—that help in achieving better glycemic control through complementary mechanisms. The extended-release formulation ensures a steady release of the drug, reducing dosage frequency and improving compliance.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps maintain blood glucose levels in combination with diet and exercise
Benefits:
-
Triple-action formula targets multiple pathways in blood sugar regulation
-
Reduces post-meal and fasting blood glucose
-
Supports long-term diabetes management
-
Lowers the risk of diabetes-related complications
Composition (per tablet):
-
Glimepiride 2 mg – Stimulates insulin release from pancreatic β-cells
-
Metformin 500 mg (Extended Release) – Decreases glucose production and improves insulin sensitivity
-
Voglibose 0.2 mg – Delays carbohydrate absorption in the intestine
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Nausea, vomiting
-
Abdominal discomfort, bloating
-
Diarrhea
-
Metallic taste
-
Flatulence
Safety Advice:
-
Take the medicine with meals to reduce gastrointestinal side effects
-
Monitor blood sugar regularly while on this medication
-
Avoid alcohol as it may increase the risk of lactic acidosis and hypoglycemia
-
Inform your doctor if you have kidney, liver, or heart conditions
-
Not recommended during pregnancy or breastfeeding unless advised by a doctor
-
Do not skip meals to avoid hypoglycemia
